reports
Edison issues report on Worldwide Healthcare Trust (WWH)
Edison Investment Research Limited Edison issues report on Worldwide Healthcare Trust (WWH) 09-Dec-2024 / 12:17 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 9 December 2024 Edison issues report on Worldwide Healthcare Trust (WWH) Edison issues report on Worldwide Healthcare Trust (LSE: WWH). Worldwide Healthcare Trust (WWH) will be celebrating its 30th birthday in 2025 and, despite more recent underperformance, the trust has served its shareholders well over the long term. Its NAV and share price total returns of +4,770% and ...
- Pedro Fonseca
Worldwide Healthcare Trust - Strong performance since inception
Worldwide Healthcare Trust (WWH) will be celebrating its 30th birthday in 2025 and, despite more recent underperformance, the trust has served its shareholders well over the long term. Its NAV and share price total returns of +4,770% and +4,181% respectively, since launch in April 1995 to the end of September 2024, are considerably ahead of the benchmark’s +2,438% total return. Co-managers, Sven Borho and Trevor Polischuk, at global healthcare specialist OrbiMed, remain bullish on the industry o...
Edison issues report on Worldwide Healthcare Trust (WWH)
Edison Investment Research Limited Edison issues report on Worldwide Healthcare Trust (WWH) 23-May-2024 / 09:59 GMT/BST The issuer is solely responsible for the content of this announcement. London, UK, 23 Mai 2024 Edison issues report on Worldwide Healthcare Trust (WWH) to view the full report. All reports published by Edison are available to download free of charge from its website Edison is authorised and regulated by the . Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any s...
- Pedro Fonseca
Worldwide Healthcare Trust - ‘Innovation, innovation, innovation’ say ...
Worldwide Healthcare Trust’s (WWH’s) co-managers, Sven Borho and Trevor Polischuk, at global healthcare specialist OrbiMed, are bullish on the outlook for the healthcare industry. They believe that high levels of innovation will be the most important driver of the sector’s performance, although continued robust levels of product approvals and an acceleration in M&A activity are also important considerations. The managers’ successful long-term strategy of favouring emerging (smaller-cap) biotech ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.